Eslicarbazepine: a novel antiepileptic agent designed for improved efficacy and safety.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2009 AND VI 44 AND IP 12
Results: 11
1
2
Fibromyalgia: a review of management options.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
3
FDA actions in brief.
- Published in:
- 2009
- Publication type:
- Journal Article
4
Selected orphan diseases.
- Published in:
- Formulary, 2009, v. 44, n. 12, p. 376
- Publication type:
- Article
5
Generic drugs dominate market, look to expand into biologics.
- Published in:
- Formulary, 2009, v. 44, n. 12, p. 374
- By:
- Publication type:
- Article
6
Fibromyalgia: A review of management options.
- Published in:
- Formulary, 2009, v. 44, n. 12, p. 362
- By:
- Publication type:
- Article
7
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety.
- Published in:
- Formulary, 2009, v. 44, n. 12, p. 357
- By:
- Publication type:
- Article
8
FDA actions in brief.
- Published in:
- Formulary, 2009, v. 44, n. 12, p. 356
- Publication type:
- Article
9
New combination.
- Published in:
- Formulary, 2009, v. 44, n. 12, p. 355
- Publication type:
- Article
10
New indication.
- Published in:
- Formulary, 2009, v. 44, n. 12, p. 355
- Publication type:
- Article
11
Pipeline preview.
- Published in:
- Formulary, 2009, v. 44, n. 12, p. 355
- Publication type:
- Article